$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
奥希替尼针对晚期肺癌的治疗效果较好
2025-10-19 11:44:20
Check Details
克唑替尼治疗ROS1重排晚期非小细胞肺癌非常有效
2025-10-19 11:44:20
Check Details
奥希替尼的适应症
2025-10-19 11:44:20
Check Details
肺癌药物奥希替尼的推荐剂量
2025-10-19 11:44:20
Check Details
奥希替尼获批用于非小细胞肺癌患者的一线治疗
2025-10-19 11:44:20
Check Details
服用奥希替尼的注意事项
2025-10-19 11:44:20
Check Details
克唑替尼可延长ALK阳性NSCLC患者的生存期
2025-10-19 11:44:20
Check Details
奥希替尼有效治疗细胞学样本判断T790M状态的肺癌
2025-10-19 11:44:20
Check Details
病例报告:克唑替尼原发性耐药使用EGFR酪氨酸激酶抑制剂有效
2025-10-19 11:44:20
Check Details
奥希替尼漏服需要补服吗?
2025-10-19 11:44:20
Check Details
克唑替尼的用法用量
2025-10-19 11:44:20
Check Details
奥希替尼(泰瑞沙)的适应症
2025-10-19 11:44:20
Check Details
1
2
...
9022
9023
9024
9025
9026
9027
9028
...
10207
10208
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
2
Ponesimod PONVORY: Novel Oral Treatment Option for Multiple Sclerosis
3
Lemborexant Side Effects and Medication Safety Complete Guide
4
Pegcetacoplan Side Effects and Medication Safety Complete Guide
5
Cabotegravir Sodium Side Effects and Medication Safety Complete Guide
6
Vericiguat Side Effects and Medication Safety Complete Guide
7
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
8
Pegcetacoplan (Empaveli): Complete Guide to PNH Complement Inhibitor Treatment
9
Cabotegravir Sodium (Vocabria): Complete Guide to HIV Long-Acting Treatment and Prevention
10
Eltrombopag: Innovative TPO Receptor Agonist for Treating Thrombocytopenia - Comprehensive Drug Analysis
11
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
12
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research